IL18 and familial hyperaldosteronism: Compared to the PBS-treated group, Cas9/gNLRP3@M-N significantly reduced the levels of IL-1β, TNF-α, and IL-18 in the serum (Figure 4C-E), showing its protective effect against LPS/D-Gal-induced FH.